Where Does Day One Biopharmaceuticals Inc (DAWN) Stock Fall in the Biotechnology Field After It Is Higher By 9.50% This Week?

A rating of 86 puts Day One Biopharmaceuticals Inc (DAWN) near the top of the Biotechnology industry according to InvestorsObserver. Day One Biopharmaceuticals Inc's score of 86 means it scores higher than 86% of stocks in the industry. Day One Biopharmaceuticals Inc also received an overall rating of 72, putting it above 72% of all stocks. Biotechnology is ranked 19 out of the 148 industries.

DAWN has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on DAWN!

See Full DAWN Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Day One Biopharmaceuticals Inc Stock Today?

Day One Biopharmaceuticals Inc (DAWN) stock is trading at $16.49 as of 12:18 PM on Thursday, Mar 28, an increase of $0.70, or 4.4% from the previous closing price of $15.79. The stock has traded between $15.75 and $16.89 so far today. Volume today is low. So far 302,961 shares have traded compared to average volume of 757,596 shares. Click Here to get the full Stock Report for Day One Biopharmaceuticals Inc stock.